Univest
Univest
  • Markets

Poly Medicure (POLYMED) Share Price Falls 5.35% Today; Mid Cap Slides to Rs 1,468

  • October 21, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Poly Medicure Share Price
Poly Medicure (POLYMED) share price fell to Rs 1,468 today, down 5.35% from the previous close. Market cap was Rs 15,721.16 crore.

Poly Medicure Share Price is trading at Rs 1,468, down 5.35% today, with market capitalisation at Rs 15,721.16 crore. The move places Poly Medicure in the Mid Cap category and brings the Poly Medicure Share Price back into focus for investors tracking healthcare names. The price move is confirmed in Univest data; a company-specific reason has not been established. The stock opened at Rs 1,557.05, touched the same intraday high, and later moved to a low of Rs 1,467.30. For readers following Poly Medicure Share Price Today and Poly Medicure Stock News, the session is notable because the fall occurred without a verified news trigger in the available record, making price action, valuation and peer context the main lenses for analysis.

Poly Medicure Share Price Today matters because the stock is being watched not just for the decline, but also for how its valuation compares with the healthcare peer set. The latest Univest figures show a richer P/E than the sector median and a P/B above the sector median, while ROE and ROCE sit close to the middle of the same-industry range. That combination makes the Poly Medicure Share Price useful for investors looking at both market reaction and fundamental context.

Table of Contents

Toggle
  • Poly Medicure (POLYMED) Share Price Today: Price Action Analysis
  • Poly Medicure (POLYMED) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Poly Medicure
  • About Poly Medicure
  • Track Poly Medicure Share Price on Univest
  • Frequently Asked Questions
    • Why is Poly Medicure Share Price falling today?
    • What is Poly Medicure Share Price today?
    • What is the market capitalisation of Poly Medicure ?
    • How does Poly Medicure Share Price compare with sector valuation?
    • What do ROE and ROCE show for Poly Medicure Share Price?
    • What does Poly Medicure EPS mean for investors?
    • What is the book value for Poly Medicure Share Price?
    • Does Poly Medicure pay a dividend?
    • How does Poly Medicure compare with healthcare peers?

Poly Medicure (POLYMED) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,468
Previous Close Rs 1,551
Today's Move -Rs 83.00 (-5.35%)
Open Rs 1,557.05
High Rs 1,557.05
Low Rs 1,467.3
Market Capitalisation Rs 15,721.16 crore
Market Cap Category Mid Cap

Poly Medicure Share Price Today shows a clear intraday decline from Rs 1,551, the previous close, to Rs 1,468, a fall of Rs 83. The stock opened at Rs 1,557.05, matched that as its day high, and touched a low of Rs 1,467.30. The day range therefore stayed tight at the top and then shifted lower through the morning. With a market capitalisation of Rs 15,721.16 crore, Poly Medicure remains a Mid Cap company, so the Poly Medicure Share Price is being assessed in a size bucket that often attracts both growth and valuation scrutiny. For today’s trade, the important fact is the direction and scale of the fall, not a separate trend narrative. The Poly Medicure Share Price is lower, the price move is verified, and the market is still pricing the stock in real time as of 21 October 2026 at 12:22:53 PM IST. That sets up the fundamental read-through that follows.

Poly Medicure (POLYMED) Fundamental Analysis

Metric Value
Market Capitalisation Rs 15,721.16 crore
P/E Ratio 49.9x
P/B Ratio 4.94x
ROE 10.94%
ROCE 14.05%
EPS Rs 31.09
Book Value Per Share Rs 313.97
Dividend Yield 0.23%

Poly Medicure (POLYMED) fundamental metrics show P/E 49.9x, P/B 4.94x, ROE 10.94%, ROCE 14.05%. These ratios show where the company stands today and are not a call to buy or sell.

Poly Medicure has a market capitalisation of Rs 15,721.16 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.9x, P/B at 4.94x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.94% and ROCE of 14.05%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 31.09, book value per share of Rs 313.97, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.48x, median ROE of 12.34%, median ROCE of 13.82%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Medical Equipment/Supplies/Accessories
Benchmark Scope same industry
Company P/E Ratio 49.9x
Benchmark Median P/E 32.48x
Benchmark Average P/E 84.01x
Benchmark P/E Range 8.46x to 910.91x
Company P/B Ratio 4.94x
Benchmark Median P/B 3.16x
Benchmark Average P/B 3.66x
Company ROE 10.94%
Benchmark Median ROE 12.34%
Benchmark Average ROE 15.27%
Company ROCE 14.05%
Benchmark Median ROCE 13.82%
Benchmark Average ROCE 16.7%
Company Market Capitalisation Rs 15,721.16 crore
Benchmark Median Market Cap Rs 173.25 crore
Benchmark Average Market Cap Rs 6,086.71 crore

Poly Medicure (POLYMED) operates in the Healthcare sector, within the Medical Equipment/Supplies/Accessories industry.

Poly Medicure (POLYMED) has a P/E ratio of 49.9x, which is above the benchmark median of 32.48x, a difference of +53.63%. A P/E difference of this kind is a reference point rather than a recommendation.

Poly Medicure (POLYMED) has a ROE of 10.94%, which is below the benchmark median of 12.34%, a difference of -11.35%. Poly Medicure (POLYMED) has a ROCE of 14.05%, which is above the benchmark median of 13.82%, a difference of +1.66%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
LENSKART SOLUTIONS LENSKART 1,11,141.66 169.59 12.43 6.85 12.55
Q-LINE BIOTECH QLINE 1,400.97 25.14 2.87 25.55 22.23
3B Blackbio Dx 3BBLACKBIO 1,141.5 20.56 3.42 20.22 25.9
LAXMI DENTAL LAXMIDENTL 1,003.19 32.48 4.09 11.95 13.29
Hemant Surgical Industries HSIL 899.3 49.44 6.25 12.73 13.58

Poly Medicure (POLYMED) has a P/E ratio of 49.9x compared with the displayed peer median of 32.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.94% compares with a peer median of 12.73% across the companies shown in the table. ROCE stood at 14.05% versus the displayed peer median of 13.58%, providing a capital-efficiency comparison. Poly Medicure (POLYMED) has a market capitalisation of Rs 15,721.16 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Poly Medicure

  • Poly Medicure Share Price is down 5.35% in today’s trade, with the decline confirmed as a live price event on Univest.
  • The stock’s P/E of 49.9 and P/B of 4.94 keep Poly Medicure Share Price in a richer valuation bracket than the industry median.
  • ROE of 10.94% and ROCE of 14.05% give investors a clear profitability and capital-return reference point.
  • Poly Medicure Share Price is being assessed alongside same-industry peers where several names trade at lower multiples.
  • The company’s Rs 15,721.16 crore market capitalisation places it well above the benchmark average and many listed peers.

About Poly Medicure

Poly Medicure operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The company is part of the mid-sized listed universe in terms of category, but its market capitalisation is materially above the same-industry average. Poly Medicure Share Price is therefore read alongside its business profile as a healthcare equipment name rather than only as a price chart event. The company description in the current record points to its place within medical equipment and supplies, and that industry position is what frames its valuation, peer set and market relevance. For readers tracking Poly Medicure Stock News, the business context matters as much as the day’s decline.

Track Poly Medicure Share Price on Univest

Use Poly Medicure (POLYMED) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Investors can track Poly Medicure Share Price on Univest for live updates, valuation ratios, 52-week levels and market insights in one place. The platform also helps users follow Poly Medicure Share Price Today alongside Poly Medicure Fundamental Analysis, peer comparison and sector context. For regular monitoring, Univest keeps the stock view tied to price action, financial ratios and company-level facts.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Poly Medicure Share Price falling today?

Ans. Poly Medicure Share Price is lower by 5.35% today and is trading at Rs 1,468. According to Univest data, the price event is confirmed, but no company-specific catalyst is established in the available record.

What is Poly Medicure Share Price today?

Ans. Poly Medicure Share Price is trading at Rs 1,468, down Rs 83 from the previous close of Rs 1,551. The stock opened at Rs 1,557.05 and touched a low of Rs 1,467.30 during the current trade.

What is the market capitalisation of Poly Medicure ?

Ans. Poly Medicure has a market capitalisation of Rs 15,721.16 crore. In the same industry benchmark, that is above the average market cap and well above the median, which matters for Poly Medicure Share Price analysis.

How does Poly Medicure Share Price compare with sector valuation?

Ans. Poly Medicure Share Price trades at a P/E of 49.9 and a P/B of 4.94. Both are above the same-industry median, so the stock sits in a richer valuation zone than the benchmark middle.

What do ROE and ROCE show for Poly Medicure Share Price?

Ans. ROE is 10.94% and ROCE is 14.05% for Poly Medicure Share Price. ROCE is slightly above the sector median, while ROE is below the median, giving investors a mixed but factual profitability picture.

What does Poly Medicure EPS mean for investors?

Ans. Poly Medicure has an EPS of Rs 31.09, which shows earnings attributable to each share. For Poly Medicure Share Price, EPS helps investors judge whether the current valuation is backed by per-share earnings power.

What is the book value for Poly Medicure Share Price?

Ans. Book value stands at Rs 313.97 per share. For Poly Medicure Share Price, this is the accounting net worth behind each share and is useful when comparing the stock’s P/B ratio with peers and the sector.

Does Poly Medicure pay a dividend?

Ans. Poly Medicure has a dividend yield of 0.23%. That means the current payout reference is modest, so dividend yield is a small part of the Poly Medicure Share Price story compared with valuation and earnings metrics.

How does Poly Medicure compare with healthcare peers?

Ans. In peer comparison, Poly Medicure Share Price sits above several listed peers on valuation, while its market capitalisation is much larger than the smaller companies in the group. That scale difference is important in relative analysis.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply